MiMedx Options Bears Win Big on CEO Split

Skepticism has been building on MDXG both in and out of the options pits

Jul 2, 2018 at 10:08 AM
facebook twitter linkedin


A number of top executives have resigned at MiMedx Group Inc (NASDAQ:MDXG) amid an ongoing internal investigation over the biopharmaceutical firm's accounting practices. Most recently, CEO Pete Petit and Chief Operating Officer Bill Taylor are out, following the early June departure of the company's chief financial officer. In reaction, MDXG stock has plummeted 33.3% to trade at $4.27 -- fresh off a four-year low of $4.15.

It's been a devastating year for MDXG shares. Since topping out at a record high of $18.25 back on Jan. 29, the stock has shed more than three-quarters of its value -- due mostly to bear gaps related to both the internal and federal investigations currently underway on MiMedx.

Amid this downtrend, skepticism has been picking up -- which has likely exacerbated the selling pressure. For starters, short interest is up 38% since mid February to 50.86 million shares, a record high. These bearish bettors are sidelined for today and tomorrow's holiday-shortened session, though, with MDXG hitting the short-sale restricted list right out of the gate.

Pessimism has been building in the options pits, too. At the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), MDXG stock's 10-day put/call volume ratio of 6.74 ranks in the 73rd annual percentile, meaning puts have been bought to open over calls at a quicker-than-usual clip in recent weeks.

Data from the major options exchanges confirms heavy buy-to-open activity at the July 5 put back on June 19, with the ask price for the options closing that day at $0.57. At last check, these puts were bid at $0.90, meaning those that bought them nine trading days ago are now looking at a substantial profit.

 

Stop leaving money on the table with the same old broken options trading approach...

There is no options strategy that more perfectly capitalizes during earnings season better than this simple call and put buying strategy. Perfect for aggressive traders looking to recover their suffering portfolios so far in 2022. With the simplest possible options strategy, Schaeffer's team with 100+ years of options trading excellence, target 200% gains on every single trade. So many trades are being beaten down by the market, but don't be one of them! Don't waste another second... join us right now before the next trade is released! 

 
Best stocks for October and worst stocks for October
 


 


 
Special Offers from Schaeffer's Trading Partners